Biosyent Inc. (RX) — Capital Reinvestment Ratio

Latest as of September 2025: 0.09x

Biosyent Inc. (RX) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$2.77 Million) in capital expenditures (CA$240.32K). See Biosyent Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.09x
Capex / Operating Cash Flow

Operating Cash Flow

CA$2.77 Million
CAD

Capital Expenditures

CA$240.32K
CAD

Data as of

Sep 2025
Most recent filing

Biosyent Inc. Capital Reinvestment Ratio (2002–2024)

This chart tracks Biosyent Inc.'s Capital Reinvestment Ratio across 18 annual periods.

Annual Capital Reinvestment Ratio for Biosyent Inc. (2002–2024)

Year-by-year Capital Reinvestment Ratio for Biosyent Inc. from 2002 to 2024. For live market cap and broader valuation context, see market value of Biosyent Inc..

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 0.54x CA$8.66 Million CA$4.67 Million ▲ +17.4%
2023 0.46x CA$5.83 Million CA$2.67 Million ▲ +337.4%
2022 0.10x CA$4.95 Million CA$519.32K ▲ +426.5%
2021 0.02x CA$4.67 Million CA$93.18K ▼ -21.2%
2020 0.03x CA$6.89 Million CA$174.30K ▼ -83.6%
2019 0.15x CA$4.77 Million CA$734.13K ▲ +91.9%
2018 0.08x CA$6.29 Million CA$504.02K ▼ -18.1%
2017 0.10x CA$6.55 Million CA$640.48K ▲ +6.2%
2016 0.09x CA$4.40 Million CA$405.46K ▼ -77.4%
2015 0.41x CA$2.81 Million CA$1.15 Million ▲ +1876.3%
2014 0.02x CA$3.64 Million CA$75.19K ▼ -66.6%
2013 0.06x CA$2.12 Million CA$130.96K ▼ -13.0%
2012 0.07x CA$1.25 Million CA$88.75K ▲ +121.4%
2011 0.03x CA$596.08K CA$19.13K ▼ -89.8%
2007 0.31x CA$14.25K CA$4.48K ▲ +772.4%
2006 0.04x CA$222.26K CA$8.02K ▲ +1526.9%
2005 0.00x CA$747.81K CA$1.66K ▼ -90.5%
2002 0.02x CA$905.12K CA$21.14K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow